CFTY720D2405: Fingolimod after natalizumab observational study

• Research type

  Research Study

• Full title

  CFTY720D2405 TRANSITION: A two-year observational study to evaluate the safety profile of fingolimod in patients with multiple sclerosis who switch from natalizumab to fingolimod

• IRAS ID

  112091

• Contact name

  Jane Watson

• Contact email

  jane.watson@novartis.com

• Sponsor organisation

  Novartis Healthcare Pvt. Ltd

• REC name

  South Central - Berkshire B Research Ethics Committee

• REC reference

  12/SC/0569

• Date of REC Opinion

  27 Dec 2012

• REC opinion

  Further Information Favourable Opinion